rs6815704

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001510.4(GRID2):​c.89-36716G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 151,930 control chromosomes in the GnomAD database, including 4,657 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4657 hom., cov: 32)

Consequence

GRID2
NM_001510.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.81

Publications

3 publications found
Variant links:
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]
GRID2 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 18
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001510.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRID2
NM_001510.4
MANE Select
c.89-36716G>A
intron
N/ANP_001501.2
GRID2
NM_001440459.1
c.89-36716G>A
intron
N/ANP_001427388.1
GRID2
NM_001286838.1
c.89-36716G>A
intron
N/ANP_001273767.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRID2
ENST00000282020.9
TSL:1 MANE Select
c.89-36716G>A
intron
N/AENSP00000282020.4
GRID2
ENST00000510992.5
TSL:1
c.89-36716G>A
intron
N/AENSP00000421257.1
GRID2
ENST00000505687.5
TSL:1
n.261-36716G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.222
AC:
33743
AN:
151812
Hom.:
4638
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.395
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.154
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.268
Gnomad NFE
AF:
0.158
Gnomad OTH
AF:
0.219
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.222
AC:
33804
AN:
151930
Hom.:
4657
Cov.:
32
AF XY:
0.217
AC XY:
16122
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.395
AC:
16373
AN:
41414
American (AMR)
AF:
0.153
AC:
2341
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
627
AN:
3468
East Asian (EAS)
AF:
0.169
AC:
868
AN:
5142
South Asian (SAS)
AF:
0.175
AC:
842
AN:
4816
European-Finnish (FIN)
AF:
0.123
AC:
1295
AN:
10560
Middle Eastern (MID)
AF:
0.281
AC:
82
AN:
292
European-Non Finnish (NFE)
AF:
0.158
AC:
10729
AN:
67964
Other (OTH)
AF:
0.217
AC:
458
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1271
2542
3814
5085
6356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.161
Hom.:
1701
Bravo
AF:
0.234
Asia WGS
AF:
0.238
AC:
827
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.030
DANN
Benign
0.28
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6815704; hg19: chr4-93474566; API